Contact
searchSearch
HMP Global
Login

Obsessive-Compulsive and Related Disorders Topic Center

Featured

John Grant, MD
Your Questions Answered
Distinguishing Visual Hallucinations, OCD Imagery, and Anxiety
03/28/2024

Featuring John Grant, MD

Featuring John Grant, MD
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores...
03/28/2024
Psych Congress Network
Do men or women have an earlier age at onset of OCD?
Quiz
Do men or women have an earlier age at onset of OCD?
03/22/2024
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your...
03/22/2024
Psych Congress Network
Mortality Risk May Be Higher in People With OCD
News
Mortality Risk May Be Higher in People With OCD
02/01/2024
Evi Arthur
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive...
02/01/2024
Psych Congress Network
brain network
News
Comorbid Tics, Stereotypies Common in Typically Developing Patients, Review Finds
01/09/2024
Jolynn Tumolo
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often...
01/09/2024
Psych Congress Network
News
Perseverative Behaviors Warrant Attention in Patients With Huntington Disease
12/28/2023
Jolynn Tumolo
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of...
12/28/2023
Neurology
From Neurology
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
News
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
12/28/2023
Jolynn Tumolo
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep...
12/28/2023
Psych Congress Network
Pop quiz!
Quiz
What is the duration of a “time-consuming” compulsion in OCD?
12/28/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/28/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
What percentage of patients with OCD have a lifetime tic disorder?
Quiz
What percentage of patients with OCD have a lifetime tic disorder?
08/23/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
08/23/2023
Psych Congress Network
Brain region graphic
News
TMS Shows Promise in Effective Obsessive-Compulsive Disorder Treatment
08/11/2023
Meagan Thistle
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and...
08/11/2023
Psych Congress Network
News
Preteen Screen Time Linked With Heightened Risk of OCD
12/16/2022
Tom Valentino
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing...
12/16/2022
Addiction Professional
From Addiction Professional

Quizzes

Do men or women have an earlier age at onset of OCD?
Quiz
Do men or women have an earlier age at onset of OCD?
03/22/2024
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your...
03/22/2024
Psych Congress Network
Pop quiz!
Quiz
What is the duration of a “time-consuming” compulsion in OCD?
12/28/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/28/2023
Psych Congress Network
What percentage of patients with OCD have a lifetime tic disorder?
Quiz
What percentage of patients with OCD have a lifetime tic disorder?
08/23/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
08/23/2023
Psych Congress Network
Dr Steven Chan
Expert Insights Quiz
Choosing the Right Digital Therapeutic for MDD Treatment
03/18/2025
Steven Chan, MD, MBA; Meagan Thistle
According to Psych Congress Steering Committee Member Steven Chan, MD, MBA, which of the following are important considerations when selecting and implementing digital therapeutics for the treatment of MDD?
According to Psych Congress Steering Committee Member Steven Chan, MD, MBA, which of the following are important considerations when selecting and implementing digital therapeutics for the treatment of MDD?
According to Psych Congress...
03/18/2025
Psych Congress Network
Did OUD diagnoses increase or decrease in VHA patients?
Quiz
Did OUD diagnoses increase or decrease in VHA patients?
02/25/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/25/2025
Psych Congress Network
Charles Raison headshot
Expert Insights Quiz
First-Line Treatment Options for Insomnia
02/21/2025
Charles L. Raison, MD
True or False: According to Psych Congress Steering Committee Member, Charles Raison, MD, the first-line treatment for primary insomnia is medication, including benzodiazepines.
True or False: According to Psych Congress Steering Committee Member, Charles Raison, MD, the first-line treatment for primary insomnia is medication, including benzodiazepines.
True or False: According to...
02/21/2025
Psych Congress Network
Quiz
Quiz
Cariprazine FDA-Approved Indications
02/21/2025
Meagan Thistle
Is cariprazine FDA-approved as an adjunctive treatment for major depressive disorder (MDD)? What is another FDA-approved indication for this drug? Take the quiz to test your psychopharmacology knowledge!
Is cariprazine FDA-approved as an adjunctive treatment for major depressive disorder (MDD)? What is another FDA-approved indication for this drug? Take the quiz to test your psychopharmacology knowledge!
Is cariprazine FDA-approved as...
02/21/2025
Psych Congress Network
How many US Psychiatric Hospitals Provided Medications for OUD?
Quiz
How many US psychiatric hospitals provided medications for OUD?
02/06/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/06/2025
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
DSM-5 Quiz: Mood Symptoms in Schizophrenia
02/03/2025
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
02/03/2025
Psych Congress Network
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How can clinicians help patients with ADHD transition from adolescence to adulthood?
Quiz
How can clinicians help patients with ADHD transition from adolescence to adulthood?
01/22/2025
Do you remember this interview with Dr Wilens?
Do you remember this interview with Dr Wilens?
Do you remember this interview...
01/22/2025
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
Quiz
Conditions That Mimic ADHD in Pediatric Patients
01/21/2025
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
01/21/2025
Psych Congress Network
Quiz
Quiz
What percentage of people experience hypomanic symptoms during an MDD episode?
01/15/2025
Meagan Thistle
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study...
01/15/2025
Psych Congress Network

News & Insights

John Grant, MD
Your Questions Answered
Distinguishing Visual Hallucinations, OCD Imagery, and Anxiety
03/28/2024

Featuring John Grant, MD

Featuring John Grant, MD
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores...
03/28/2024
Psych Congress Network
Mortality Risk May Be Higher in People With OCD
News
Mortality Risk May Be Higher in People With OCD
02/01/2024
Evi Arthur
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive...
02/01/2024
Psych Congress Network
brain network
News
Comorbid Tics, Stereotypies Common in Typically Developing Patients, Review Finds
01/09/2024
Jolynn Tumolo
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often...
01/09/2024
Psych Congress Network
News
Perseverative Behaviors Warrant Attention in Patients With Huntington Disease
12/28/2023
Jolynn Tumolo
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of...
12/28/2023
Neurology
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
News
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
12/28/2023
Jolynn Tumolo
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep...
12/28/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
Brain region graphic
News
TMS Shows Promise in Effective Obsessive-Compulsive Disorder Treatment
08/11/2023
Meagan Thistle
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and...
08/11/2023
Psych Congress Network
News
Preteen Screen Time Linked With Heightened Risk of OCD
12/16/2022
Tom Valentino
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing...
12/16/2022
Addiction Professional
News
FDA Clears Brainsway TMS as a Treatment for OCD
08/17/2018
The Brainsway Deep Transcranial Magnetic Stimulation (TMS) System can be marketed as a treatment for obsessive compulsive disorder (OCD), the US Food and Drug Administration (FDA) announced.
The Brainsway Deep Transcranial Magnetic Stimulation (TMS) System can be marketed as a treatment for obsessive compulsive disorder (OCD), the US Food and Drug Administration (FDA) announced.
The Brainsway Deep Transcranial...
08/17/2018
Psych Congress Network
Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
Study on MDD - stock image
News
Phase II Trial of AL001 for MDD Set to Begin Later this Year
03/24/2025
Jolynn Tumolo
Plans have been announced for a phase II clinical study of investigational lithium therapy AL001 for MDD, focusing on its unique properties and its effect on lithium delivery in the brain compared with marketed lithium salts.
Plans have been announced for a phase II clinical study of investigational lithium therapy AL001 for MDD, focusing on its unique properties and its effect on lithium delivery in the brain compared with marketed lithium salts.
Plans have been announced for a...
03/24/2025
Psych Congress Network
US FDA sign
News
FDA Seeks Clearer Labeling for Transmucosal Buprenorphine Product Dosing
03/24/2025
Jolynn Tumolo
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that...
03/24/2025
Psych Congress Network
3 medical professionals stand together talking in the hallway of a medical facility
News
Accelerated Theta-Burst Stimulation Protocol Improves Treatment-Resistant Depression
03/21/2025
Jolynn Tumolo
A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to results from a randomized clinical trial published in JAMA Psychiatry.
A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to results from a randomized clinical trial published in JAMA Psychiatry.
A novel 78-minute accelerated...
03/21/2025
Psych Congress Network
an older man wearing glasses rubs his face in stress tired depression treatment resistant depression
News
Genetic Predispositions to Insomnia, Neuroticism, Linked With Higher Risk for Treatment-Resistant Depression
03/18/2025
Jolynn Tumolo
A genetic predisposition to traits including neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistant depression (TRD) in a cohort study published in JAMA Psychiatry.
A genetic predisposition to traits including neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistant depression (TRD) in a cohort study published in JAMA Psychiatry.
A genetic predisposition to...
03/18/2025
Psych Congress Network
Woman sitting at bar holding a drink.
News
Semaglutide Reduces Cravings in Adults with Alcohol Use Disorder
03/13/2025
Jolynn Tumolo
Nine weeks of low-dose semaglutide decreased the amount of alcohol consumed, relative to placebo, in a laboratory test involving adults with AUD who were not seeking treatment, study finds.
Nine weeks of low-dose semaglutide decreased the amount of alcohol consumed, relative to placebo, in a laboratory test involving adults with AUD who were not seeking treatment, study finds.
Nine weeks of low-dose...
03/13/2025
Psych Congress Network
emergency room hospital waiting room reception area
News
Why Aren’t More Emergency Departments Using Medications for OUD Treatment?
03/12/2025
Jolynn Tumolo
Barriers may be hampering the use of medications for opioid use disorder (MOUD) in US emergency departments (EDs), according to results from a systematic review published in the Journal of Substance Use & Addiction Treatment.
Barriers may be hampering the use of medications for opioid use disorder (MOUD) in US emergency departments (EDs), according to results from a systematic review published in the Journal of Substance Use & Addiction Treatment.
Barriers may be hampering the...
03/12/2025
Psych Congress Network
stethoscope with research images in background medical study clinical trial research
News
Machine Learning Predicts Progression to Schizophrenia Within 5 Years
03/12/2025
Jolynn Tumolo
Machine learning models used routine clinical data from electronic health records to predict progression to schizophrenia and bipolar disorder within 5 years for patients with pre-existing mental illness, according to a study published in...
Machine learning models used routine clinical data from electronic health records to predict progression to schizophrenia and bipolar disorder within 5 years for patients with pre-existing mental illness, according to a study published in...
Machine learning models used...
03/12/2025
Psych Congress Network
two researchers look at computer screen in lab medical research
News
Continuous D2 Blockade in First-Episode Schizophrenia Does Not Raise Relapse Risk
03/05/2025
Jolynn Tumolo
More than 5 years of continuous treatment with dopamine D2 receptor-blocking long-acting injectable (LAI) antipsychotics does not appear to increase the risk of breakthrough psychosis in patients with first-episode schizophrenia.
More than 5 years of continuous treatment with dopamine D2 receptor-blocking long-acting injectable (LAI) antipsychotics does not appear to increase the risk of breakthrough psychosis in patients with first-episode schizophrenia.
More than 5 years of continuous...
03/05/2025
Psych Congress Network
A doctor and patient talk
News
Later Life Depressive Symptoms Not Linked With Amyloid Accumulation
03/04/2025
Jolynn Tumolo
In older adults with normal cognition, depressive symptoms were not consistently associated with amyloid pathology. Meanwhile, depressive symptoms were associated with a reduced likelihood of amyloid pathology in older adults with mild...
In older adults with normal cognition, depressive symptoms were not consistently associated with amyloid pathology. Meanwhile, depressive symptoms were associated with a reduced likelihood of amyloid pathology in older adults with mild...
In older adults with normal...
03/04/2025
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use